The article is about how people who invest in the marijuana business are now more interested in looking at numbers and money stuff instead of just where the plants can grow. The lawyers and other experts say that they need to use special ways to figure out how much a company is worth because it's still a new and different kind of business with lots of rules and changes. Read from source...

1. The title of the article is misleading and does not accurately represent the content. It implies that there are some new insights from industry experts on cannabis valuations, but in reality, most of the quotes are from lawyers and equity analysts who do not have direct involvement or knowledge of the cannabis market.
2. The article fails to provide any data or evidence to support the claims that cannabis valuations have become more mathematical and balance sheet driven. It relies on anecdotal opinions from a few individuals, which are not representative of the whole industry.
3. The article does not address the underlying factors that drive cannabis valuations, such as market demand, supply chain challenges, competition, regulatory environment, tax implications, etc. It only focuses on the financial aspects and ignores other important variables that affect the value of a cannabis business.
4. The article uses vague terms like "wishy-washy" and "more mathematical" without defining them or explaining how they have changed over time. These terms are subjective and do not provide any useful information for readers who want to understand the dynamics of cannabis valuations better.

Neutral

Key points from the article:
- Cannabis valuations are becoming more mathematical and balance sheet driven than before.
- Legal uncertainties influence financial evaluations of cannabis companies.
- Equity analyst Pablo Zuanic says cannabis is not yet valued like a regular industry and uses unique metrics like EBITDA.